Penumbra Inc (Penumbra) is a medical device company that designs, develops, and manufactures products for neuro and vascular markets. Its products find use in procedures such as thrombectomy and embolization for treating conditions such as acute ischemic stroke, brain aneurysm, acute limb ischemia, deep vein thrombosis, neuro arteriovenous malformation, body aneurysm among others. Its major products include neurovascular access systems, revascularization devices, embolization coiling systems and microcatheters. The company sells its products to specialist physicians, hospitals and clinics through a direct sales organization. It also distributes its products through distributors globally. It has operations in the US, Brazil, Germany, Australia, Canada, Singapore, France and the UK. Penumbra is headquartered in Alameda, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Penumbra Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- Penumbra Inc Company Overview
- Penumbra Inc Company Snapshot
- Penumbra Inc Pipeline Products and Ongoing Clinical Trials Overview
- Penumbra Inc - Pipeline Analysis Overview
- Business Description
- Penumbra Inc - Key Facts
- Penumbra Inc - Major Products and Services
- Penumbra Inc Pipeline Products by Development Stage
- Penumbra Inc Ongoing Clinical Trials by Trial Status
- Penumbra Inc Pipeline Products Overview
- Clinical Decision-Making Tool - Pulmonary Embolism
- Clinical Decision-Making Tool - Pulmonary Embolism Product Overview
- Clot Containment System
- Clot Containment System Product Overview
- Indigo Aspiration System - Lightning Aspiration Tubing
- Indigo Aspiration System - Lightning Aspiration Tubing Product Overview
- Indigo Aspiration System - Lightning Aspiration Tubing Clinical Trial
- Indigo Aspiration System - Separator 12
- Indigo Aspiration System - Separator 12 Product Overview
- Indigo Aspiration System - Separator 12 Clinical Trial
- Indigo System Aspiration Lightning 7
- Indigo System Aspiration Lightning 7 Product Overview
- Thunderbolt
- Thunderbolt Product Overview
- Penumbra Inc - Key Competitors
- Penumbra Inc - Key Employees
- Penumbra Inc - Key Employee Biographies
- Penumbra Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Penumbra Inc, Recent Developments
- Jun 05, 2025: Penumbra Introduces the Ruby XL System - the Longest, Largest, and Softest Coil on the Market for Vascular Embolization
- Apr 02, 2025: Seven New Data Sets Demonstrate Penumbra’s Computer Assisted Vacuum Thrombectomy (CAVT) Technology Is Safe, Fast and Effective, Improves Patient Outcomes, and Delivers Healthcare Resource Benefits
- Apr 02, 2025: Seven New Data Sets Demonstrate Penumbra’s Computer Assisted Vacuum Thrombectomy (CAVT) Technology Is Safe, Fast and Effective, Improves Patient Outcomes, and Delivers Healthcare Resource Benefits
- Feb 21, 2025: Penumbra Receives 510(K) Clearance For Penumbra System Reperfusion Catheter RED 72
- Dec 26, 2024: Penumbra Receives FDA 510(k) Clearance for Access25 Delivery Microcatheter
- Dec 09, 2024: Penumbra Receives FDA 510(k) Clearance for Element Vascular Access System
- Nov 05, 2024: New Late Breaking Data Show Patients Treated with Penumbra's Computer Assisted Vacuum Thrombectomy Technology for Pulmonary Embolism Experience Shorter Hospital Stays and Fewer Complications Compared to Other Treatment Options
- Sep 16, 2024: Penumbra Receives CE Mark for Computer Assisted Vacuum Thrombectomy Technologies - Lightning Flash 2.0 and Lightning Bolt 7 - in Europe
- Sep 13, 2024: Penumbra Receives Additional 510(K) Clearance For Indigo Aspiration System
- Jul 02, 2024: Penumbra Schedules Second Quarter 2024 Earnings Release and Conference Call for July 30, 2024
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- Penumbra Inc Pipeline Products and Ongoing Clinical Trials Overview
- Penumbra Inc Pipeline Products by Equipment Type
- Penumbra Inc Pipeline Products by Indication
- Penumbra Inc Ongoing Clinical Trials by Trial Status
- Penumbra Inc, Key Facts
- Penumbra Inc, Major Products and Services
- Penumbra Inc Number of Pipeline Products by Development Stage
- Penumbra Inc Pipeline Products Summary by Development Stage
- Penumbra Inc Ongoing Clinical Trials by Trial Status
- Penumbra Inc Ongoing Clinical Trials Summary
- Clinical Decision-Making Tool - Pulmonary Embolism - Product Status
- Clinical Decision-Making Tool - Pulmonary Embolism - Product Description
- Clot Containment System - Product Status
- Clot Containment System - Product Description
- Indigo Aspiration System - Lightning Aspiration Tubing - Product Status
- Indigo Aspiration System - Lightning Aspiration Tubing - Product Description
- Indigo Aspiration System - Lightning Aspiration Tubing - STORM-PE: A Prospective, Multicenter, Randomized Controlled Trial Evaluating Anticoagulation Alone vs Anticoagulation Plus Mechanical Aspiration With the Indigo Aspiration System for the Treatment of Intermediate High Risk Acute Pulmonary Embolism
- Indigo Aspiration System - Separator 12 - Product Status
- Indigo Aspiration System - Separator 12 - Product Description
- Indigo Aspiration System - Separator 12 - STORM-PE: A Prospective, Multicenter, Randomized Controlled Trial Evaluating Anticoagulation Alone vs Anticoagulation Plus Mechanical Aspiration With the Indigo Aspiration System for the Treatment of Intermediate High Risk Acute Pulmonary Embolism
- Indigo System Aspiration Lightning 7 - Product Status
- Indigo System Aspiration Lightning 7 - Product Description
- Thunderbolt - Product Status
- Thunderbolt - Product Description
- Penumbra Inc, Key Employees
- Penumbra Inc, Key Employee Biographies
- Penumbra Inc, Subsidiaries
- Glossary
- Penumbra Inc Pipeline Products by Equipment Type
- Penumbra Inc Pipeline Products by Development Stage
- Penumbra Inc Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AngioDynamics Inc
- Medtronic Plc
- Inari Medical Inc
- Stryker Corp
- Boston Scientific Corp
- Terumo Medical Corp
